Correlation Between Dyne Therapeutics and United Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and United Therapeutics, you can compare the effects of market volatilities on Dyne Therapeutics and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and United Therapeutics.
Diversification Opportunities for Dyne Therapeutics and United Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dyne and United is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and United Therapeutics go up and down completely randomly.
Pair Corralation between Dyne Therapeutics and United Therapeutics
Considering the 90-day investment horizon Dyne Therapeutics is expected to under-perform the United Therapeutics. In addition to that, Dyne Therapeutics is 3.14 times more volatile than United Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. United Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 34,667 in United Therapeutics on August 24, 2024 and sell it today you would earn a total of 2,069 from holding United Therapeutics or generate 5.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyne Therapeutics vs. United Therapeutics
Performance |
| Timeline |
| Dyne Therapeutics |
| United Therapeutics |
Dyne Therapeutics and United Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyne Therapeutics and United Therapeutics
The main advantage of trading using opposite Dyne Therapeutics and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.| Dyne Therapeutics vs. Stoke Therapeutics | Dyne Therapeutics vs. Pliant Therapeutics | Dyne Therapeutics vs. Cytokinetics | Dyne Therapeutics vs. Revolution Medicines |
| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |